Get the app
public
ios_share
Bioverge
chevron_right
Harnessing CRISPR to Cure Infectious Diseases
Feb 1, 2023
55:47
forum
Ask episode
play_arrow
Play
view_agenda
Chapters
auto_awesome
Transcript
info_circle
Episode notes
Daniel Dornbusch, CEO of Excision BioTherapeutics, sits down with Neil to discuss his company’s efforts to develop CRISPR-based therapies to cure HIV and other viral infectious diseases.
